October 16, 2019
Seeking Alpha
Principia Biopharma is a developer of small molecule drugs for the treatment of cancer and inflammatory diseases.
Princip... Read more
Principia BioPharma's Competitors, Revenue, Number of Employees, Funding and Acquisitions
Followers on Owler
167
Followers on Owler
Based on data from Principia BioPharma's latest SEC filings
Annual Revenue
Based on data from Principia BioPharma's latest SEC filings
Employees
CEO
Martin Babler
OVERVIEW
Founded:
2008
Headquarters:
South San FranciscoCalifornia
Status:
PublicIndependent Company of NASDAQPRNB
Industry Sector:
Biotechnology
SIC Code:
2836NAICS listing »
Top Competitors or Alternatives
Missing a competitor? Contribute!
Weigh-in!
Help the Owler community know moreTrending News for Principia BioPharma and Principia BioPharma's Competitors
October 14, 2019
MarketScreener
Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial Role of Nomacopan as an Inhibitor of both C5 and LTB4 in the Ongoing Phase I/II AKC Trial
(marketscreener.com) Biopsy tissue expresses the complement C5a receptor 1 and the leukotriene LTB4 r... See more »
October 15, 2019
BioSpace
Portola Pharmaceuticals to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019
The live conference call on Tuesday, November 5, 2019, at 4:30 p.m. ET, can be accessed by phone by c... See more »
Competitive Analysis
TOP COMPETITORS OR ALTERNATIVES
Innovimmune Biotherapeutics is seen as one of Principia BioPharma's top competitors. Innovimmune Biotherapeutics's headquarters is in New York, New York, and was founded in 2010. Like Principia BioPharma, Innovimmune Biotherapeutics also works within the Biotechnology industry. Innovimmune Biotherapeutics generates 2.50% of Principia BioPharma's revenue.
ASLAN Pharmaceuticals is one of Principia BioPharma's top rivals. ASLAN Pharmaceuticals was founded in 2010, and its headquarters is in Singapore, Other. Like Principia BioPharma, ASLAN Pharmaceuticals also works within the Biotechnology field. ASLAN Pharmaceuticals has NaN fewer employees than Principia BioPharma.
RANK
COMPANY
LEADERSHIP
EMPLOYEES
TOTAL FUNDING
REVENUE
Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$79.9M
Principia BioPharma's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 3.9B. Over the last four quarters, Principia BioPharma's revenue has grown by 61.6%. Specifically, in Q2 2019's revenue was $30M; in Q1 2019, it was $5.2M; in Q4 2018, it was $26.1M; in Q3 2018, Principia BioPharma's revenue was $18.6M.
Acquisitions
No recent acquisitions found related to Principia BioPharma
Principia BioPharma Funding History
Since Principia BioPharma was founded in 2008, it has participated in 6 rounds of funding. In total Principia BioPharma has raised $246.2M. Principia BioPharma's last funding round was on Aug 2018 for a total of $50.0M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
Equity
Aug 2018
$50M
-
Total Funding: $246.2M
Since Principia BioPharma was founded in 2008, it has participated in 6 rounds of funding. In total Principia BioPharma has raised $246.2M. Principia BioPharma's last funding round was on Aug 2018 for a total of $50.0M
Investments
No recent investments found related to Principia BioPharma
Principia BioPharma News
August 27, 2019Benzinga
Principia to Present at the 2019 Baird Global Healthcare Conference and the Wells Fargo Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (NASDAQ:PRNB)... See more »
June 2, 2019Zolmax News
$8.00 Million in Sales Expected for Principia Biopharma Inc (PRNB) This Quarter
Wall Street analysts forecast that Principia Biopharma Inc (NASDAQ:PRNB) will post $8.00 million in s... See more »
May 8, 2019Finance Daily
Principia Biopharma (NASDAQ:PRNB) and Its Rivals
Principia Biopharma (NASDAQ: PRNB) is one of 553 publicly-traded companies in the "Pharmaceutical pre... See more »
April 18, 2019FirstWord Pharma
Principia Biopharma Appoints Shao-Lee Lin, M.D., Ph.D. to Board of Directors
Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing... See more »
March 11, 20194-traders
, AbbVie End Oral Immunoproteasome Collaboration
(marketscreener.com) By Colin Kellaher Principia Biopharma on Monday said it is ending its collaborat... See more »
March 11, 2019pipelinereview
Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
SOUTH SAN FRANCISCO, CA, USA I March 11, 2019 I Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage... See more »
March 4, 2019StreetInsider
Principia Biopharma Inc. (PRNB) Highlights Positive Data from Phase 2 Pemphigus Vulgaris Trial at AAD Meetings
Principia Biopharma Inc. (NASDAQ: PRNB) today announced Phase 2 clinical data from the Believe-PV stu... See more »
Principia BioPharma Press Releases
May 14, 2019GlobeNewswire
Principia Biopharma Announces First Patient Dosed in Sanofi's Phase 2b Trial of SAR442168 in Multiple Sclerosis, Triggering $30 Million Milestone
SOUTH SAN FRANCISCO, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB)... See more »
May 9, 2019GlobalNewswire
Principia Biopharma to Present at the 2019 Bank of America Merrill Lynch Health Care Conference
SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB)... See more »
May 7, 2019GlobeNewswire
Principia Biopharma Reports First Quarter Financial Results
SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB)... See more »
May 7, 2019StreetInsider
Principia Biopharma Reports First Quarter Financial Results
SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB)... See more »
March 20, 2019GlobeNewswire
Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results
SOUTH SAN FRANCISCO, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRN... See more »
March 1, 2019GlobeNewswire
Principia Biopharma Presents Phase 1 Clinical Data from CNS Penetrating BTK Inhibitor Candidate PRN2246/SAR442168 at ACTRIMS 2019
-- Orally administered PRN2246 achieved full BTK occupancy in peripheral blood ---- PRN2246 exhibited... See more »
February 22, 2019GlobeNewswire
Principia Biopharma Announces the Acceptance of Data from Phase 2 Pemphigus Vulgaris Trial as a Late-Breaking Presentation at 2019 American Academy of Dermatology Meeting
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB... See more »
Principia BioPharma Videos
Headquarters
Trending Companies
IN THE NEWS
Dollar Tree | Adobe | Vertex | Android | TipTop Poultry | CIRC Hotel | Pan American Silver | Newell Rubbermaid | Lam Research | Risen Energy | Boeing | Universal Display | Sina | ACI Worldwide | Hawaiian Airlines | Jindal Steel & Power | Shinhint Industries | Novartis | Jacobs | Avago | Kimberly-Clark | Tesla | Essex | Southern Company | Depop | Federal Realty | 3M | GMC Roofing and Building Paper Products | Carter's | HCA | Therrel Baisden PA | j2 Global | Silicon Motion | Teladoc | Boston Scientific | Chevron | E*TRADE | Ryder | KeyBank | BD | SBA Communications | Delta | King Ursa | AutoZone | Hyundai Motor | Western Digital | Macy's | BellRing Brands | Valero | Fabrinet
PEOPLE ALSO VIEWED
Miele USA | Morriz Of Sweden | Cassiopae | Crawford-Butz & Associates | Aurora Health Care | Ninja Marketing | TriggerMail | Royall & Company | Exmark | Yardi Matrix | Intalere | Bashas' | Polishworks Auto Detail | The Park Savoy Estate | Unilend | TECSOL | Vision | BridgeView Partners | EnergyCAP | Memorado | Iraa Enterprises. . Refund | J2 Clothing | Profilgruppen | Ombrange | Hair Surgeon | Marriage Radio | La Cote D'azur | Columbus Delivery and Logistics | MSM | Oale-inox
Summary
ABOUT
Overview
Principia Biopharma is a developer of small molecule drugs for the treatment of cancer and inflammatory diseases. Principia BioPharma was founded in 2008. Principia BioPharma's headquarters is located in South San Francisco, California, USA 94080. It ...
CEO
Principia BioPharma's CEO, Martin Babler, currently has an approval rating of 75%. Principia BioPharma's primary competitors are Innovimmune Biotherapeutics, ASLAN Pharmaceuticals & Akari.Website
principiabio.comFrequently Asked Questions about Principia BioPharma
When was Principia BioPharma founded?
Principia BioPharma was founded in 2008Who is Principia BioPharma's CEO?
Principia BioPharma's CEO is Martin BablerHow much revenue does Principia BioPharma generate?
Principia BioPharma generates $79.9M in revenueHow much funding does Principia BioPharma have?
Principia BioPharma has historically raised $246.2M in funding
Where is Principia BioPharma's headquarters?
Principia BioPharma's headquarters is in South San Francisco California, USAHow many employees does Principia BioPharma have?
Principia BioPharma has 69 employeesWhat sector does Principia BioPharma operate in?
Principia BioPharma is in BiotechnologyWho are Principia BioPharma's competitors?
Principia BioPharma's top competitors are Innovimmune Biotherapeutics, ASLAN Pharmaceuticals, Akari
